Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Compounded medications are not FDA-approved drugs
Datopotamab deruxtecan (Dato-DXd) vs chemotherapy in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2) breast cancer (BC): Primary results from the randomised phase III TROPION-Breast01 trial
The analytical data obtained were found to be consistent with the existing literature 48
Free shipment protection on every order Third-party tested CoA on file Discreet, tracked shipping Free shipping over $200 Members earn 5% back in store credit What is GHK-Cu
US$ 25.18
US$ 21.86
US$ 28.44
US$ 27.76
US$ 29.08
